A Single Dose, Open-Label, Randomized, Two-Way Crossover Pivotal Study to Assess the Bioequivalence of a New ULTRACET ER Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted Condition
Latest Information Update: 16 Jul 2013
At a glance
- Drugs Tramadol/paracetamol (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Janssen
- 04 Feb 2013 New trial record
- 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.